Christina Bennett, MS

Christina Bennett, MS, is an independent medical journalist who writes about a variety of medical topics, including oncology, health care policy, and cell and gene therapies. She has a bachelor's degree in biomedical science and a master’s degree in science and technology journalism, both from Texas A&M University. She is a member of the Association of Healthcare Journalists and the National Association of Science Writers and was one of a dozen journalists selected for the 2017 National Cancer Reporting Fellowships.

All articles by Christina Bennett, MS

Preparing patients for treatment toxicity is important for ensuring that mild or moderate reactions

Chronic Lymphocytic Leukemia

Comorbidities Signal Worse Outcomes in CLL After Targeted Treatment

Christina Bennett, MS

October 18, 2018

High comorbidity burden was associated with worse survival outcomes in patients with chronic lymphocytic leukemia who were treated with ibrutinib.

Cancer Therapy Advisor interviewed Dr Bakal about this new approach to analyzing cell shape and its

Chronic Myeloid Leukemia

Potential Diagnostic Tool Detects BCR-ABL1 mRNA in Chronic Myeloid Leukemia

Christina Bennett, MS

October 17, 2018

A new method for rapid, ultrasensitive detection of BCR-ABL1 mRNA in chronic myeloid leukemia was described; the tool may have diagnostic utility.

TLS considered an emergency, so it’s crucial to initiate therapy as soon as possible.

Head and Neck Cancer

Treatment Delays May Mean Worse Survival in Head and Neck Cancer

Christina Bennett, MS

October 16, 2018

Prolonged postoperative and radiation intervals were associated with worse survival outcomes in patients with head and neck cancer.

A large, retrospective cohort study found no evidence that metformin prevents lung cancer, although

Chronic Myeloid Leukemia

New Combo for Chronic Myeloid Leukemia Shows Activity In Vitro

Christina Bennett, MS

October 16, 2018

The addition of AR-42 to imatinib yielded synergistic activity in chronic myeloid leukemia cells and also appeared to reverse therapeutic resistance.

HPV Update: Increased Incidence of Throat Cancer

Head and Neck Cancer

Age-adjusted Comorbidity Predicts Survival in Laryngeal Cancer

Christina Bennett, MS

October 16, 2018

Age and pretreatment comorbidities were shown to impact survival outcomes in patients with locally advanced laryngeal cancer.

The FDA has granted Priority Review to the Biologics License Application for avelumab for the treatm

Bladder Cancer

Role of miR-125a-5p Clarified in Bladder Cancer

Christina Bennett, MS

October 15, 2018

Researchers clarified the role of miR-125a-5p in bladder cancer, showing that it inhibits bladder cancer progression by targeting oncogene FUT4.

Traditional genetic testing historically included the sequential analysis of single and generally we

Bladder Cancer

Bladder Cancer Clinical Features Linked to EGFR and HER2 Expression

Christina Bennett, MS

October 15, 2018

A retrospective study found EGFR and HER2 overexpression associated with clinical features, such as tumor stage and tumor recurrence, in bladder cancer tissue.

Good clinical outcomes are possible after surgery for high-risk patients with early stage lung cance

Hematologic Cancers

Fecal Transplantation Restores Patient Gut Microbiota Following Allo-HSCT

Christina Bennett, MS

October 9, 2018

After antibiotic treatment during allogeneic hematopoietic stem cell transplantation, fecal transplantation was shown to restore patients’ gut microbiota.